294 related articles for article (PubMed ID: 32774148)
21. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
22. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
Lake AD; Novak P; Hardwick RN; Flores-Keown B; Zhao F; Klimecki WT; Cherrington NJ
Toxicol Sci; 2014 Jan; 137(1):26-35. PubMed ID: 24097666
[TBL] [Abstract][Full Text] [Related]
23. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous nonalcoholic fatty liver disease and ER stress in Sidt2 deficiency mice.
Gao J; Zhang Y; Yu C; Tan F; Wang L
Biochem Biophys Res Commun; 2016 Aug; 476(4):326-332. PubMed ID: 27233614
[TBL] [Abstract][Full Text] [Related]
25. Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease.
Guo R; Liong EC; So KF; Fung ML; Tipoe GL
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):139-44. PubMed ID: 25865685
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism.
De Nardo W; Miotto PM; Bayliss J; Nie S; Keenan SN; Montgomery MK; Watt MJ
Mol Metab; 2022 Jun; 60():101491. PubMed ID: 35381388
[TBL] [Abstract][Full Text] [Related]
27. [ER stress and NAFLD].
Lachkar F; Papaioannou A; Ferré P; Foufelle F
Biol Aujourdhui; 2020; 214(1-2):15-23. PubMed ID: 32773026
[TBL] [Abstract][Full Text] [Related]
28. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
[TBL] [Abstract][Full Text] [Related]
29. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease.
Yan Z; Miao X; Zhang B; Xie J
Life Sci; 2018 Dec; 215():64-72. PubMed ID: 30473026
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
31. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.
Yang M; Chen Z; Xiang S; Xia F; Tang W; Yao X; Zhou B
BMC Complement Med Ther; 2020 Dec; 20(1):377. PubMed ID: 33308192
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.
Lebeaupin C; Vallée D; Hazari Y; Hetz C; Chevet E; Bailly-Maitre B
J Hepatol; 2018 Oct; 69(4):927-947. PubMed ID: 29940269
[TBL] [Abstract][Full Text] [Related]
33. Unfolded Protein Response Sensors in Hepatic Lipid Metabolism and Nonalcoholic Fatty Liver Disease.
Henkel AS
Semin Liver Dis; 2018 Nov; 38(4):320-332. PubMed ID: 30357769
[TBL] [Abstract][Full Text] [Related]
34. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
35. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
36. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
[TBL] [Abstract][Full Text] [Related]
37. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
[TBL] [Abstract][Full Text] [Related]
38. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
39. Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non-alcoholic fatty liver disease.
Dai Y; Xu R; Chen J; Fang J; Zhang H; Li H; Chen W
Br J Pharmacol; 2024 Apr; 181(7):967-986. PubMed ID: 37940413
[TBL] [Abstract][Full Text] [Related]
40. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
